PTU - Polskie Towarzystwo Urologiczne
list of articles:

COMPARAIWE EVALUATION OF BCG AND ADRIBLASTIN EFFICACY IN THE TREATMENT OF SUPERFICIAL BLADDER TUMOURS
Article published in Urologia Polska 1997/50/2.

authors

Piotr Kaczmarek, Eugeniusz Miękoś
Klinika Urologii Instytutu Chirurgii WAM w Łodzi
Kierownik Kliniki: prof. dr hab. med. E. Miękoś

keywords

bladder bladder carcinoma BCG-therapy

summary

Objective. The authors present the results of two years observation of 65 patients with
superficial bladder tumours.
Material and method. After electroresection of tumours 22 (34%) patients were given
instillations BCG, 26 (40%) patients were given instillations Adriblastin, but 19 (22%)
patients were not given any medicine (the patients didn't come for the next part of
treatment).
Results. During the further observation of the patients, it come out that in the grup I ?
BCG there was no recurrent tumour with 13 (59%) patients, in the grup II ? ADR there
was no recurrent tumour with 11 (42%) patients, Comparing to only 4 (21%) patients in the III grup.
Conclusions. BCG intravesical instillations after transurethral electroresection were
the most effective in the superficial bladder tumours treatment.

references

  1. [1] Bretton, P. R., Hen, A. W., Kimmel, M.: The response of patients with supper-
  2. ficial bladder cancer to a second of intrauesical BCG. J. Urol., 1990 Apr., 143 (4),
  3. 710-712.
  4. [2] Catalowa, W. I., Ratliff, T. L.: Bacillus Calmette-Guerin and superficial blad-
  5. der cancer. Clinical experience and mechanism of action. Surg. Ann., 1990, 22,
  6. 363-378.
  7. [3] D'Ancona, C. A., Netto Junior, N. R., Claro, J. A.: Oral or intravesical
  8. bacillus Calmette-Guerin immunoprophylaxsis in bladder carcinoma. J. Urol., 1991
  9. Mar., 145 (3), 498-501.
  10. [4] Franssen, M. P. H., de Mulder, P. H. M., Doesburg, W. H.: Combination
  11. therapy with recombinat interferon - alpha and - gamma in advanced renal cell
  12. carcinoma - a phase I -II study. Immunotherapy of urological tumors, Chur-
  13. chill Livingstone, 1990,163-171.
  14. [5] Graziano, D. A., Jacobs, D., Lozano, R. G., Buck, R. O.: A case of granulo-
  15. matous hepatitis after intravesical Bacillus Calmette - Guerin administration. }.
  16. Urol., 1991,146(4), 1118-1119.
  17. [6] Khanna, O. R, Son, D. L., Macer, H., Read, )., Nugent, D.: Multicenter
  18. study of superficial bladder cancer treated with intravesical bacillus Calmette-Gu-
  19. erin or adriamycin. Urology, 1990, 35(2), 101-108.
  20. [7] Lamm, D. L.: Adriamycin vs. BCG in superficial bladder cancer. Interface 11,1989.
  21. [8] Lamm, D. L., De Haven, J. I., Shriver, J.: Prospectwe randomized Compari-
  22. son of intravesical with Percutaneous bacillus Calmette - Guerinuersus intrauesical
  23. BCG in superficial bladder cancer. J. Urol., 1991,145(4), 738-740.
  24. [9] Martinez Pineiro, J. A., Martinez Pineiro Jr., ]., Garcia Motres, J.: BCG
  25. vs. dozorubicin vs. thiotepa instilation for primary superficial bladder cancer. Immu-
  26. notherapy of Urological Tumours, Society Internationale D'Urologie, 1990,59-
  27. 68.
  28. [10] Rubben, H., Weissbach, L., Knebel, L.: Adjuyant systemic chemotherapy after
  29. complete transurethral resection of superficially invasive bladder carcinoma.
  30. (T 1 G 3-4 andT2G 2-4). Urol. Int., 1990, 45(2), 78-83.
  31. [11] Rubben, H., Graf Doberstein, C.: Prospectwe rondomized study of adjuyant
  32. therapy after complete resection of superficial bladder cancer., mitomycin C vs. BCG
  33. Connaught vs. TUR alone. Immunotherapy of urological tumors, Society In-
  34. ter-nationale D'Urologie, 1990, 27-36.
  35. [12] Steg, A., Adjiman, S., Debre, B.: BCG therapy in superficial bladder tumours
  36. complication and precautions. Eur. Urol., 1992, 21 (supp 2), 35-40.
  37. [13] Yamamoto, T., Hagiwara, M., Nakazano, M.: Intravesical bacillus Calmette -
  38. Guerin in the treatment of superficial bladder cancer. Prospectw randomized study for
  39. prophilactic effect. Nippon Hinyokika Gakkai Zsshi, 1990, 81(7), 997-1001.
  40. [14] Zieliński, J.: Onkologia urologiczna, PZWL, 1986.